Chrissy Metz Embraces GLP-1 After Years of Skepticism

Metz told E! News that her initial resistance stemmed from a desire to remain diligent about what she put into her body, particularly following the COVID-19 pandemic. The decision to move forward was rooted in a desire to quiet the persistent mental preoccupation with food, which she described as food noise. Beyond weight management, she noted that the medication has positively impacted her blood work and inflammation levels, ultimately fostering a sense of creative freedom that she previously lacked.

Her experience contrasts with other public figures navigating similar health journeys. While Kris Jenner reported negative side effects from GLP-1 treatments, opting instead for peptide injections and supplements, Metz views her own transition as a path toward better overall health. By partnering with the digital health company Ro, Metz now hopes her transparency will encourage others to move past the societal shame often attached to weight-loss choices and explore options that may improve their quality of life.